loadpatents
Patent applications and USPTO patent grants for Moreau; Beno t.The latest application filed is for "targeted conjugates encapsulated in particles and formulations thereof".
Patent | Date |
---|---|
Targeted Conjugates Encapsulated In Particles And Formulations Thereof App 20220288229 - Bilodeau; Mark T. ;   et al. | 2022-09-15 |
Compounds, Compositions, And Methods For The Treatment Of Cancers App 20220185836 - BILODEAU; Mark T. ;   et al. | 2022-06-16 |
Hsp90-targeting Conjugates And Formulations Thereof App 20220096640 - Moreau; Beno t ;   et al. | 2022-03-31 |
HSP90-targeting conjugates and formulations thereof Grant 11,241,500 - Moreau , et al. February 8, 2 | 2022-02-08 |
Hsp90-targeting Conjugates And Formulations Thereof App 20220031853 - WHITE; Brian H. ;   et al. | 2022-02-03 |
Hsp90-targeting Conjugates And Formulations Thereof App 20210145971 - Bilodeau; Mark T. ;   et al. | 2021-05-20 |
Hsp90-targeting Conjugates And Formulations Thereof App 20210000966 - Cipriani; Tyler ;   et al. | 2021-01-07 |
Sstr-targeted Conjugates Encapsulated In Particles And Formulations Thereof App 20200121808 - Bilodeau; Mark T. ;   et al. | 2020-04-23 |
Hsp90-targeting Conjugates And Formulations Thereof App 20200085960 - Moreau; Beno t ;   et al. | 2020-03-19 |
Targeted Constructs And Formulations Thereof App 20200009262 - White; Brian H. ;   et al. | 2020-01-09 |
Platinum Compounds, Compositions, And Uses Thereof App 20190350940 - Alargova; Rossitza G. ;   et al. | 2019-11-21 |
Platinum compounds having a heterocycle ligand, nanoparticles, and uses thereof Grant 10,472,380 - Brockman , et al. Nov | 2019-11-12 |
Compounds, Compositions, And Methods For The Treatment Of Cancers App 20190218241 - Bilodeau; Mark T. ;   et al. | 2019-07-18 |
Platinum compounds, compositions, and uses thereof Grant 10,342,801 - Alargova , et al. July 9, 2 | 2019-07-09 |
Compounds, compositions, and methods for the treatment of cancers Grant 10,287,308 - Bilodeau , et al. | 2019-05-14 |
Targeted Conjugates And Particles And Formulations Thereof App 20190125888 - White; Brian H. ;   et al. | 2019-05-02 |
Compounds, Compositions, And Methods For The Treatment Of Cancers App 20190015378 - Bilodeau; Mark T. ;   et al. | 2019-01-17 |
Compounds, compositions, and methods for the treatment of cancers Grant 10,111,853 - Bilodeau , et al. October 30, 2 | 2018-10-30 |
Compounds, Compositions, And Methods For The Treatment Of Cancers App 20180273567 - Bilodeau; Mark T. ;   et al. | 2018-09-27 |
Platinum Compounds, Compositions, And Uses Thereof App 20180243318 - Alargova; Rossitza G. ;   et al. | 2018-08-30 |
Platinum Compounds, Compositions, And Uses Thereof App 20180186823 - Kadiyala; Sudhakar ;   et al. | 2018-07-05 |
Compounds, compositions, and methods for the treatment of cancers Grant 10,011,622 - Bilodeau , et al. July 3, 2 | 2018-07-03 |
Platinum compounds, compositions, and uses thereof Grant 9,937,187 - Bilodeau , et al. April 10, 2 | 2018-04-10 |
Targeted Conjugates Encapsulated In Particles And Formulations Thereof App 20180021454 - Bilodeau; Mark T. ;   et al. | 2018-01-25 |
Platinum Compounds, Compositions, And Uses Thereof App 20180008614 - Bilodeau; Mark T. ;   et al. | 2018-01-11 |
Platinum Compounds Having A Heterocycle Ligand, Nanoparticles, And Uses Thereof App 20170349615 - Brockman; Adam H. ;   et al. | 2017-12-07 |
Compounds, Compositions, And Methods For The Treatment Of Cancers App 20170313733 - Bilodeau; Mark T. ;   et al. | 2017-11-02 |
Platinum compounds having a heterocycle ligand, nanoparticles, and uses thereof Grant 9,771,387 - Brockman , et al. September 26, 2 | 2017-09-26 |
Compounds, compositions, and methods for the treatment of cancers Grant 9,738,672 - Bilodeau , et al. August 22, 2 | 2017-08-22 |
Compounds, Compositions, And Methods For The Treatment Of Cancers App 20170087118 - Bilodeau; Mark T. ;   et al. | 2017-03-30 |
Compounds, compositions, and methods for the treatment of cancers Grant 9,556,214 - Bilodeau , et al. January 31, 2 | 2017-01-31 |
Compounds, Compositions, And Methods For The Treatment Of Cancers App 20160326201 - Bilodeau; Mark T. ;   et al. | 2016-11-10 |
Platinum Compounds, Compositions, And Uses Thereof App 20160317549 - Bilodeau; Mark T. ;   et al. | 2016-11-03 |
Compounds, Compositions, And Methods For The Treatment Of Cancers App 20160318962 - Bilodeau; Mark T. ;   et al. | 2016-11-03 |
Platinum compounds, compositions, and uses thereof Grant 9,403,858 - Bilodeau , et al. August 2, 2 | 2016-08-02 |
Platinum Compounds Having A Heterocycle Ligand, Nanoparticles, And Uses Thereof App 20160152646 - Brockman; Adam H. ;   et al. | 2016-06-02 |
Cytomegalovirus inhibitor compounds Grant 9,315,499 - Fader , et al. April 19, 2 | 2016-04-19 |
Platinum Compounds, Compositions, And Uses Thereof App 20160068557 - Bilodeau; Mark T. ;   et al. | 2016-03-10 |
Compounds, Compositions, And Methods For The Treatment Of Cancers App 20150344511 - Bilodeau; Mark T. ;   et al. | 2015-12-03 |
Cytomegalovirus Inhibitor Compounds App 20150158861 - Fader; Lee ;   et al. | 2015-06-11 |
Platinum Compounds, Compositions And Methods For The Treatment Of Cancer App 20140088066 - Bilodeau; Mark T. ;   et al. | 2014-03-27 |
Hepatitis C Inhibitor Compounds App 20120077737 - Llinas-Brunet; Montse ;   et al. | 2012-03-29 |
Hepatitis C Inhibitor Compounds App 20110294778 - LLINAS-BRUNET; Montse ;   et al. | 2011-12-01 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.